Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

04:29 EDT 2nd October 2014 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 390,000+

Thursday 2nd October 2014

WHO: Best scenario puts Ebola vaccine late Q1 2015

But even under the best conditions and with the massive efforts of many partners, a significant number of doses will not be available until late in the first quarter of 2015, the WHO panel acknowledged.

Novartis quits hepatitis C

Novartis has decided to throw in the towel over hepatitis C. "As part of an ongoing portfolio transformation, hepatitis C virus (HCV) will no longer be a strategic focus," the pharma major has confirmed. As a result, Novartis has terminated its licen...

LDC Enters Collaboration with the Helmholtz Association

The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and the Helmholtz Association, Germany’s biggest scientific organization, will be collaborating more closely in future. An initial pilot project in cooperation wi...

Eurofins Genomics Extends Its Genomic Business In Italy

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Italy, located in Vimodrone, Milan. With the acquisition of the oligonucleotide synthesis and DNA sequencing business from Primm S.r....

UPDATE 7-Dallas Ebola patient vomited outside apartment on way to hospital

DALLAS, Oct 1 (Reuters) - Two days after he was sent home from a Dallas hospital, the man who is the first person to be diagnosed with Ebola in the United States was seen vomiting on the ground outside an apartment complex as he was bundled into an a...

Esperion's ETC-1002 succeeds in Phase IIb, but Zetia combo could be key

BRIEF-Philips Electronics says will appeal jury verdict in patent infringement lawsuit by Masimo

* Philips to appeal verdict in patent infringement lawsuit in US

German stocks - Factors to watch on October 2

FRANKFURT, Oct 2 (Reuters) - The DAX top-30 index is expected to open 0.1 percent lower on Thursday, according to premarket data from brokerage Lang & Schwarz at 0607 GMT.

BRIEF-Biofrontera says clinical program for US approval of Ameluz approaches completion

* Says clinical program for US approval of Ameluz approaches completion: studies confirm excellent efficacy and safety

BRIEF-Ipsen CFO Susheel Surpal steps down

* Susheel Surpal will step down as Chief Financial Officer of Ipsen as of Oct. 31

BRIEF-Bayer successfully places $7 bln jumbo bond

* Net cash provided by the bond will replace part of bridge financing secured in connection with takeover of Merck & Co's OTC unit Source text: http://bit.ly/1vzhWkb Further company coverage:

BRIEF-Sonova completes acquisition of Comfort Audio

* Says completed previously announced acquisition of Comfort Audio i Halmstad AB (Sweden), following regulatory approvals Source text for Eikon: Further company coverage:

Exclusive: U.S. nears solution for safe disposal of Ebola waste

WASHINGTON/CHICAGO (Reuters) - The United States is days away from settling the critical question of how hospitals should handle and dispose of medical waste from Ebola patients, a government official said on Wednesday.

Wednesday 1st October 2014

Site-specific group selection drives locally adapted group compositions

Group selection may be defined as selection caused by the differential extinction or proliferation of groups. The socially polymorphic spider Anelosimus studiosus exhibits a behavioural polymorphism in which females exhibit either a ‘docile’ or ...

Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness

Systemic infection induces conserved physiological responses that include both resistance and ‘tolerance of infection’ mechanisms. Temporary anorexia associated with an infection is often beneficial, reallocating energy from food foraging towards...

High winter ozone pollution from carbonyl photolysis in an oil and gas basin

The United States is now experiencing the most rapid expansion in oil and gas production in four decades, owing in large part to implementation of new extraction technologies such as horizontal drilling combined with hydraulic fracturing. The environ...

The genetics of monarch butterfly migration and warning colouration

The monarch butterfly, well known for its spectacular annual migration across North America, is shown by genome sequencing of monarchs from around the world to have been ancestrally migratory and to have dispersed out of North America to occupy its c...

Pulmonary macrophage transplantation therapy

This study reports the correction of pulmonary alveolar proteinosis (PAP) in Csf2rb–/– mice by a single transfer of either wild-type or gene-corrected macrophages directly to the lungs — the transplanted macrophages persisted for at least 1 ye...

Animal behaviour: Incipient tradition in wild chimpanzees

The adoption of a new form of tool use has been observed to spread along social-network pathways in a chimpanzee community. The finding offers the first direct evidence of cultural diffusion in these animals in the wild.

Lung disease: Treatment by cell transplant

Transplanting gene-corrected macrophage cells directly into the lungs of mice has been shown to effectively treat their pulmonary alveolar proteinosis, a hereditary lung disease also found in humans.

Immunology: Starve a fever, feed the microbiota

A study finds that the cells lining the gut are modified in response to systemic infection, increasing the host's tolerance to infection in a manner that is dependent on the microorganisms that inhabit the gut.

Evolutionary biology: Survival of the fittest group

Experiments with social spiders find that colony size and composition affect colony survival in a site-specific manner, indicating that natural selection on group-level traits contributes to local adaptation.

Genomics: Of monarchs and migration

The genomes of 101 monarch butterflies from migratory and resident populations have been sequenced, revealing genes and molecular pathways that underlie insect migration and colouration.

New Tax Rules May Deter Future Pharma M&A

Inversions in the pharmaceutical sector could become less lucrative as a result of new tax laws.

PharmTech 2015 Editorial Calendar

PharmTech 2015 Editorial Calendar


Search BioPortfolio:
Loading
Advertisement
Advertisement